Sreyashi Basu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Venues

Nature communications

Nature medicine

Science translational medicine

Cancer immunology research

Lady Brabourne College (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Lady Brabourne College

India

BSC :: Chemistry

University of Calcutta

India

MSC :: Biochemistry

University of Connecticut Health Center

United States

PHD :: Immunology

Publications

Swetha Anandhan, Shelley Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Daniel Macaluso, Sonali Jindal, Seanu Meena Natarajan, Samuel W Andrewes, Liangwen Xiong, Ashwat Nagarajan, Sreyashi Basu, Derek Ng Tang, Jielin Liu, Jimin Min, Anirban Maitra, Padmanee Sharma
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature communications 15 (1) (2024)
Matthew T Campbell, Amishi Yogesh Shah, Pavlos Msaouel, Nizar M Tannir, Arlene O Siefker-Radtke, Ashish M Kamat, Neema Navai, Colin P N Dinney, Priya Rao, Charles C Guo, Rahul A Sheth, Aradhana M Venkatesan, Rebecca S Slack Tidwell, Shalini Singh Yadav, Aidi Gu, Hong Chen, Marc Macaluso, Fei Duan, Sreyashi Basu, Sonali Jindal, Padmanee Sharma
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle Invasive Bladder Cancer. Cancer research communications (2024)
Swetha Anandhan, Shelley Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Daniel Macaluso, Sonali Jindal, Seanu Meena Natarajan, Samuel W Andrewes, Liangwen Xiong, Ashwat Nagarajan, Sreyashi Basu, Derek Ng Tang, Jielin Liu, Jimin Min, Anirban Maitra, Padmanee Sharma
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature communications 15 (1) (2024)
Bilal A Siddiqui, Nicolas L Palaskas, Sreyashi Basu, Yibo Dai, Zhong He, Shalini Singh Yadav, James P Allison, Rahul A Sheth, Sudhakar Tummala, Louis Maximilian Buja, Meenakshi B Bhattacharjee, Cezar A Iliescu, Anishia Rawther-Karedath, Anita Deswal, Linghua Wang, Padmanee Sharma, Sumit K Subudhi
Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis. Cancer immunology research 12 (8) (2024)
Bilal A Siddiqui, Nicolas L Palaskas, Sreyashi Basu, Yibo Dai, Zhong He, Shalini Singh Yadav, James P Allison, Rahul A Sheth, Sudhakar Tummala, Louis Maximilian Buja, Meenakshi B Bhattacharjee, Cezar A Iliescu, Anishia Rawther-Karedath, Anita Deswal, Linghua Wang, Padmanee Sharma, Sumit K Subudhi
Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositis. Cancer immunology research (2024)
Swetha Anandhan, Shelley Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Daniel Macaluso, Sonali Jindal, Seanu Meena Natarajan, Samuel W Andrewes, Liangwen Xiong, Ashwat Nagarajan, Sreyashi Basu, Derek Ng Tang, Jielin Liu, Jimin Min, Anirban Maitra, Padmanee Sharma
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature communications 15 (1) (2024)
Swetha Anandhan, Shelley Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Daniel Macaluso, Sonali Jindal, Seanu Meena Natarajan, Samuel W Andrewes, Liangwen Xiong, Ashwat Nagarajan, Sreyashi Basu, Derek Ng Tang, Jielin Liu, Jimin Min, Anirban Maitra, Padmanee Sharma
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature communications 15 (1) (2024)
Sangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, Seanu Meena Natarajan, Yulong Chen, Candice Poon, Mercedes Hennessey, Aminah J Tannir, Jan Zhang, Swetha Anandhan, Brittany Parker Kerrigan, Marc D Macaluso, Zhong He, Sonali Jindal, Frederick F Lang, Sreyashi Basu, Padmanee Sharma
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade. Nature cancer (2023)
Moran Amit, Erez Nissim Baruch, Priyadahrshini Nagarajan, Frederico Omar Gleber-Netto, Xiayu Rao, Tongxin Xie, Shamima Akhter, Adebayo Adewale, Shajedul Islam, Brandi Mattson, Renata Ferrarotto, Michael Wong, Michael A Davies, Sonali Jindal, Sreyashi Basu, Catherine Harwood, Irene Leigh, Nadim J Ajami, P Andrew Futreal, Micah Castillo, Preethi Gunarante, Ryan Goepfert, Nikhil Khushalani, Jing Wang, Stephanie S Watowich, George Adrian Calin, Michael Migden, Paola Drapkin Vermeer, Nisha D'Silva, Dan Yaniv, Jared K Burks, Javier Gomez, Patrick Dougherty, Kenneth Y Tsai, James Allison, Padmanee Sharma, Jennifer A Wargo, Jeffrey Myers, Neil D Gross
Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade. Research square (2023)
Cascone Tina, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter, Myrna C B Godoy, Hope Feldman, William N William, Yuanxin Xi, Sreyashi Basu, Jing Jing Sun, Shalini S Yadav, Frank R Rojas Alvarez, Younghee Lee, Aditya K Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo Vailati Negrão, Xiuning Li, Carl M Gay, Anne S Tsao, Lauren Averett Byers, Mehmet Altan, Bonnie S Glisson, Frank V Fossella, Yasir Y Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Ravi Rajaram, Mara B Antonoff, Junya Fujimoto, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Cara L Haymaker, Ignacio I Wistuba, Stephen G Swisher, Ara A Vaporciyan, Heather Y Lin, Jing Wang, Don L Gibbons, Jiun-Kae Jack Lee, Nadim J Ajami, Jennifer A Wargo, James P Allison, Padmanee Sharma, Humam Kadara, John Victor Heymach, Boris Sepesi
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nature medicine 29 (3) (2023)
Cascone Tina, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter, Myrna C B Godoy, Hope Feldman, William N William, Yuanxin Xi, Sreyashi Basu, Jing Jing Sun, Shalini S Yadav, Frank R Rojas Alvarez, Younghee Lee, Aditya K Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo Vailati Negrão, Xiuning Li, Carl M Gay, Anne S Tsao, Lauren Averett Byers, Mehmet Altan, Bonnie S Glisson, Frank V Fossella, Yasir Y Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Ravi Rajaram, Mara B Antonoff, Junya Fujimoto, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Cara L Haymaker, Ignacio I Wistuba, Stephen G Swisher, Ara A Vaporciyan, Heather Y Lin, Jing Wang, Don L Gibbons, Jiun-Kae Jack Lee, Nadim J Ajami, Jennifer A Wargo, James P Allison, Padmanee Sharma, Humam Kadara, John Victor Heymach, Boris Sepesi
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nature medicine (2023)
Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, Fei Duan, Sreyashi Basu, Shalini S Yadav, Ai-Di Gu, Alexsandra B Espejo, Michelle Kinder, Curtis A Pettaway, John F Ward, Rebecca S Slack Tidwell, Patricia Troncoso, Paul G Corn, Christopher J Logothetis, Roland Knoblauch, Natalie Hutnick, Marco Gottardis, Charles G Drake, Padmanee Sharma, Sumit K Subudhi
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor). Journal for immunotherapy of cancer 11 (3) (2023)
Cascone Tina, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter, Myrna C B Godoy, Hope Feldman, William N William, Yuanxin Xi, Sreyashi Basu, Jing Jing Sun, Shalini S Yadav, Frank R Rojas Alvarez, Younghee Lee, Aditya K Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo Vailati Negrão, Xiuning Li, Carl M Gay, Anne S Tsao, Lauren Averett Byers, Mehmet Altan, Bonnie S Glisson, Frank V Fossella, Yasir Y Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Ravi Rajaram, Mara B Antonoff, Junya Fujimoto, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Cara L Haymaker, Ignacio I Wistuba, Stephen G Swisher, Ara A Vaporciyan, Heather Y Lin, Jing Wang, Don L Gibbons, Jiun-Kae Jack Lee, Nadim J Ajami, Jennifer A Wargo, James P Allison, Padmanee Sharma, Humam Kadara, John Victor Heymach, Boris Sepesi
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nature medicine 29 (3) (2023)
Cascone Tina, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter, Myrna C B Godoy, Hope Feldman, William N William, Yuanxin Xi, Sreyashi Basu, Jing Jing Sun, Shalini S Yadav, Frank R Rojas Alvarez, Younghee Lee, Aditya K Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo Vailati Negrão, Xiuning Li, Carl M Gay, Anne S Tsao, Lauren Averett Byers, Mehmet Altan, Bonnie S Glisson, Frank V Fossella, Yasir Y Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Ravi Rajaram, Mara B Antonoff, Junya Fujimoto, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Cara L Haymaker, Ignacio I Wistuba, Stephen G Swisher, Ara A Vaporciyan, Heather Y Lin, Jing Wang, Don L Gibbons, Jiun-Kae Jack Lee, Nadim J Ajami, Jennifer A Wargo, James P Allison, Padmanee Sharma, Humam Kadara, John Victor Heymach, Boris Sepesi
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nature medicine 29 (3) (2023)
Nitin Jain, Jayastu Senapati, Beenu Thakral, Alessandra Ferrajoli, Phillip A Thompson, Jan A Burger, Sreyashi Basu, Tapan M Kadia, Naval G Daver, Gautam Borthakur, Marina Konopleva, Naveen Pemmaraju, Erin M Parry, Catherine J Wu, Joseph D Khoury, Carlos E Bueso-Ramos, Naveen Garg, Xuemei Wang, Wanda Lopez, Ana Ayala, Susan M O'Brien, Hagop M Kantarjian, Michael J Keating, James P Allison, Padmanee Sharma, William G Wierda
A Phase 2 Study of Nivolumab Combined with Ibrutinib in Patients with Diffuse Large B-cell Richter Transformation of CLL. Blood advances (2022)
Pavlos Msaouel, Sangeeta Goswami, Peter F Thall, Xuemei Wang, Ying Yuan, Eric Jonasch, Jianjun Gao, Matthew T Campbell, Amishi Yogesh Shah, Paul Gettys Corn, Alda L Tam, Kamran Ahrar, Priya Rao, Kanishka Sircar, Lorenzo Cohen, Sreyashi Basu, Fei Duan, Sonali Jindal, Yuwei Zhang, Hong Chen, Shalini Singh Yadav, Ronald Shazer, Hirak Der-Torossian, James P Allison, Padmanee Sharma, Nizar M Tannir
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Science translational medicine 14 (641) (2022)
Sumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, Shalini S Yadav, Sreyashi Basu, Hong Chen, Sonali Jindal, Rebecca S Slack Tidwell, Ashwin Varma, Christopher J Logothetis, James P Allison, Paul G Corn, Padmanee Sharma
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment. Journal for immunotherapy of cancer 9 (10) (2022)
Sangeeta Goswami, Yulong Chen, Swetha Anandhan, Peter M Szabo, Sreyashi Basu, Jorge M Blando, Wenbin Liu, Jan Zhang, Seanu Meena Natarajan, Liangwen Xiong, Baoxiang Guan, Shalini Singh Yadav, Abdel Saci, James P Allison, Matthew D Galsky, Padmanee Sharma
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC. Science translational medicine 12 (548) (2021)
Matthew T Campbell, Surena F Matin, Alda L Tam, Rahul A Sheth, Kamran Ahrar, Rebecca S Slack Tidwell, Priya Rao, Jose Antonio Karam, Christopher G Wood, Nizar M Tannir, Eric Jonasch, Jianjun Gao, Amado J Zurita, Amishi Yogesh Shah, Sonali Jindal, Fei Duan, Sreyashi Basu, Hong Chen, Alexsandra B Espejo, James P Allison, Shalini S Yadav, Padmanee Sharma
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nature communications 12 (1) (2021)
Cascone Tina, Annikka Weissferdt, Myrna C B Godoy, William N William, Cheuk H Leung, Heather Y Lin, Sreyashi Basu, Shalini S Yadav, Apar Pataer, Kyle G Mitchell, Md Abdul Wadud Khan, Yushu Shi, Cara L Haymaker, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Humam Kadara, Ignacio I Wistuba, Padmanee Sharma, James P Allison, Nadim J Ajami, Jennifer A Wargo, Robert R Jenq, Don L Gibbons, Jiun-Kae Jack Lee, Stephen G Swisher, Ara A Vaporciyan, John Victor Heymach, Boris Sepesi
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer. Nature communications 12 (1) (2021)
Renata Ferrarotto, Moran Amit, Priyardhisini Nagarajan, M Laura Rubin, Ying Yuan, Diana Bell, Adel K El-Naggar, Jason M Johnson, William H Morrison, David I Rosenthal, Bonnie S Glisson, Faye M Johnson, Charles Lu, Frank E Mott, Bita Esmaeli, Eduardo M Diaz, Paul W Gidley, Ryan P Goepfert, Carol M Lewis, Randal S Weber, Jennifer A Wargo, Sreyashi Basu, Fei Duan, Shalini Singh Yadav, Padmanee Sharma, James P Allison, Jeffrey N Myers, Neil D Gross
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
Hussein A Abbas, Dapeng Hao, Katarzyna Tomczak, Praveen Barrodia, Jin Seon Im, Patrick K Reville, Zoe Alaniz, Wei Wang, Ruiping Wang, Feng Wang, Gheath Al-Atrash, Koichi Takahashi, Jing Ning, Maomao Ding, Hannah C Beird, Jairo T Mathews, Latasha Little, Jianhua Zhang, Sreyashi Basu, Marina Y Konopleva, Mario L Marques-Piubelli, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Wei Lu, Auriole Tamegnon, Guillermo Garcia Manero, Michael R Green, Padmanee Sharma, James P Allison, Steven Mitchell Kornblau, Kunal Rai, Linghua Wang, Naval Daver, P Andrew Futreal
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy. Nature communications 12 (1) (2021)
Jianjun Gao, Neema Navai, Omar Alhalabi, Arlene Siefker-Radtke, Matthew T Campbell, Rebecca S Slack Tidwell, Charles C Guo, Ashish M Kamat, Surena F Matin, John C Araujo, Amishi Y Shah, Pavlos Msaouel, Paul Corn, Jianbo Wang, John N Papadopoulos, Shalini S Yadav, Jorge M Blando, Fei Duan, Sreyashi Basu, Wenbin Liu, Yu Shen, Yuwei Zhang, Marc Daniel Macaluso, Ying Wang, Jianfeng Chen, Jianhua Zhang, P Andrew Futreal, Colin Dinney, James P Allison, Sangeeta Goswami, Padmanee Sharma
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nature medicine 26 (12) (2020)

Sreyashi Basu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sreyashi Basu